These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9137973)

  • 21. New experimental model of multiple myeloma.
    Telegin GB; Kalinina AR; Ponomarenko NA; Ovsepyan AA; Smirnov SV; Tsybenko VV; Homeriki SG
    Bull Exp Biol Med; 2001 Jun; 131(6):609-12. PubMed ID: 11586419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Soluble B-Cell Maturation Antigen Mediates Tumor-Induced Immune Deficiency in Multiple Myeloma.
    Sanchez E; Gillespie A; Tang G; Ferros M; Harutyunyan NM; Vardanyan S; Gottlieb J; Li M; Wang CS; Chen H; Berenson JR
    Clin Cancer Res; 2016 Jul; 22(13):3383-97. PubMed ID: 26960399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma.
    Cruz JC; Alsina M; Craig F; Yoneda T; Anderson JL; Dallas M; Roodman GD
    Exp Hematol; 2001 Apr; 29(4):441-7. PubMed ID: 11301184
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin 6 is essential for in vivo development of B lineage neoplasms.
    Hilbert DM; Kopf M; Mock BA; Köhler G; Rudikoff S
    J Exp Med; 1995 Jul; 182(1):243-8. PubMed ID: 7790819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 5T2MM murine model of multiple myeloma: maintenance and analysis.
    Vanderkerken K; Asosingh K; Willems A; De Raeve H; Couck P; Gorus F; Croucher P; Van Camp B
    Methods Mol Med; 2005; 113():191-205. PubMed ID: 15968104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple genetic loci modify susceptibility to plasmacytoma-related morbidity in E(mu)-v-abl transgenic mice.
    Symons RC; Daly MJ; Fridlyand J; Speed TP; Cook WD; Gerondakis S; Harris AW; Foote SJ
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11299-304. PubMed ID: 12149518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple myeloma and related disorders. Lessons from an animal model.
    Radl J
    Pathol Biol (Paris); 1999 Feb; 47(2):109-14. PubMed ID: 10192877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A review of current murine models of multiple myeloma used to assess the efficacy of therapeutic agents on tumour growth and bone disease.
    Paton-Hough J; Chantry AD; Lawson MA
    Bone; 2015 Aug; 77():57-68. PubMed ID: 25868800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of interleukin 6 in plasmacytomagenesis.
    Hirano T; Suematsu S; Matsusaka T; Matsuda T; Kishimoto T
    Ciba Found Symp; 1992; 167():188-96; discussion 196-200. PubMed ID: 1425013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma.
    Quwaider D; Corchete LA; Misiewicz-Krzeminska I; Sarasquete ME; Pérez JJ; Krzeminski P; Puig N; Mateos MV; García-Sanz R; Herrero AB; Gutiérrez NC
    J Hematol Oncol; 2017 Apr; 10(1):92. PubMed ID: 28420429
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clonogenic precursor cell in multiple myeloma.
    Bakkus MH; Van Riet I; De Greef C; Van Camp B; Thielemans K
    Leuk Lymphoma; 1995 Jul; 18(3-4):221-9. PubMed ID: 8535186
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myeloma stem cell concepts, heterogeneity and plasticity of multiple myeloma.
    Hajek R; Okubote SA; Svachova H
    Br J Haematol; 2013 Dec; 163(5):551-64. PubMed ID: 24111932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD74 is expressed by multiple myeloma and is a promising target for therapy.
    Burton JD; Ely S; Reddy PK; Stein R; Gold DV; Cardillo TM; Goldenberg DM
    Clin Cancer Res; 2004 Oct; 10(19):6606-11. PubMed ID: 15475450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Myeloma stem/progenitor cells as new targets for therapy of multiple myeloma--review].
    Ma YL; Hou J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1459-64. PubMed ID: 19099665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extraosseous IL-6 transgenic mouse plasmacytoma sometimes lacks Myc-activating chromosomal translocation.
    McNeil N; Kim JS; Ried T; Janz S
    Genes Chromosomes Cancer; 2005 Jun; 43(2):137-46. PubMed ID: 15751044
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal circulating B cells in multiple myeloma. A continuously differentiating, possibly invasive, population as defined by expression of CD45 isoforms and adhesion molecules.
    Pilarski LM; Jensen GS
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):297-322. PubMed ID: 1533857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effect.
    Rozemuller H; van der Spek E; Bogers-Boer LH; Zwart MC; Verweij V; Emmelot M; Groen RW; Spaapen R; Bloem AC; Lokhorst HM; Mutis T; Martens AC
    Haematologica; 2008 Jul; 93(7):1049-57. PubMed ID: 18492693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PEGylated long-circulating liposomes deliver homoharringtonine to suppress multiple myeloma cancer stem cells.
    Li M; Shi F; Fei X; Wu S; Wu D; Pan M; Luo S; Gu N; Dou J
    Exp Biol Med (Maywood); 2017 May; 242(9):996-1004. PubMed ID: 28056549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BCL2 accelerates inflammation-induced BALB/c plasmacytomas and promotes novel tumors with coexisting T(12;15) and T(6;15) translocations.
    Silva S; Kovalchuk AL; Kim JS; Klein G; Janz S
    Cancer Res; 2003 Dec; 63(24):8656-63. PubMed ID: 14695177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
    Greil R; Egle A; Villunger A
    Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.